Tech Company Financing Transactions

Synta Pharmaceuticals Funding Round

Duquesne Capital Management and Gollust Management participated in a $50 million Series C venture round for Synta Pharmaceuticals. This venture round was announced on 1/14/2004.

Transaction Overview

Announced On
1/14/2004
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series C
Proceeds Purpose
This financing enables Synta to accelerate the development of its three lead clinical programs in cancer and autoimmune disease, while maintaining investment in its promising earlier-stage product candidates.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
200 Barr Harbor Dr. 400
West Conshohocken, PA 19428
USA
Phone
Undisclosed
Email Address
Overview
Synta Pharmaceuticals (Nasdaq: SNTA) is a pharmaceutical company focused on discovering, developing, and commercializing breakthrough products for severe medical conditions.
Profile
Synta Pharmaceuticals LinkedIn Company Profile
Social Media
Synta Pharmaceuticals Company Twitter Account
Company News
Synta Pharmaceuticals News
Facebook
Synta Pharmaceuticals on Facebook
YouTube
Synta Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Paul Friedman
  Paul Friedman LinkedIn Profile  Paul Friedman Twitter Account  Paul Friedman News  Paul Friedman on Facebook
Chief Financial Officer
Marc Schneebaum
  Marc Schneebaum LinkedIn Profile  Marc Schneebaum Twitter Account  Marc Schneebaum News  Marc Schneebaum on Facebook
Chief Medical Officer
Rebecca Taub
  Rebecca Taub LinkedIn Profile  Rebecca Taub Twitter Account  Rebecca Taub News  Rebecca Taub on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/14/2004: Actimize venture capital transaction
Next: 1/15/2004: BenefitPoint venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document funding rounds that are announced publicly. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary